Literature DB >> 3958139

Use of 51Cr release to measure the cytotoxic effects of staphylococcal leukocidin and toxin neutralization on bovine leukocytes.

D A Loeffler, K A Schat, N L Norcross.   

Abstract

Leukocidin toxin from Staphylococcus aureus produces specific cytolytic effects on neutrophils and macrophages. The most commonly used method for determination of leukocidin activity is microscopic examination for characteristic morphological changes in toxin-treated cells. The 51Cr release assay was modified to allow quantitation of the cytolytic effects of leukocidin on bovine peripheral blood neutrophils and lymphocytes. Toxin neutralization by serum and milk samples was quantitated by this method. The neutralizing abilities of the various samples were found to correlate with the levels of immunoglobulin G (IgG1) specific for leukocidin. Undiluted normal serum samples, however, were capable of partially preventing the cytotoxic effects of leukocidin. The assay was shown to be an effective means of quantitating the cytotoxic activity of leukocidin on neutrophils as well as demonstrating neutralization of cytotoxicity by milk and serum samples.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958139      PMCID: PMC268665          DOI: 10.1128/jcm.23.3.416-420.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Purification of the two components of leucocidin from Staphylococcus aureus.

Authors:  A M WOODIN
Journal:  Biochem J       Date:  1960-04       Impact factor: 3.857

2.  Isolation of leukocytes from bovine peripheral blood.

Authors:  G P Carlson; J J Kaneko
Journal:  Proc Soc Exp Biol Med       Date:  1973-03

3.  Local immunity on the mammary gland following the infusion of a staphylococcal cell-toxoid vaccine.

Authors:  P M Outteridge; R C Williams; A K Lascelles
Journal:  Res Vet Sci       Date:  1968-09       Impact factor: 2.534

4.  The immunisation of rabbits with staphylococcal leucocidin toxoid. With a report on the pathological histology of their internal organs.

Authors:  J Soucková-Stĕpánová; G P Gladstone; R Vanĕcek
Journal:  Br J Exp Pathol       Date:  1965-08

5.  Effect of immunization with highly purified Panton-Valentine leucocidin and delta-toxin on staphylococcal mastitis in rabbits.

Authors:  C Adlam; P D Ward; W H Turner
Journal:  J Comp Pathol       Date:  1980-04       Impact factor: 1.311

Review 6.  Mechanisms of staphylococcal virulence in relation to bovine mastitis.

Authors:  J C Anderson
Journal:  Br Vet J       Date:  1976 May-Jun

7.  Crystallization and properties of staphylococcal leukocidin.

Authors:  M Noda; T Hirayama; I Kato; F Matsuda
Journal:  Biochim Biophys Acta       Date:  1980-11-17

8.  [Cytotoxic effects of a leukocidin from Staphylococcus aureus (author's transl)].

Authors:  T Pfanneberg; H Blobel; W Schaeg
Journal:  Zentralbl Bakteriol Orig A       Date:  1975-10

9.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

10.  Immunization with leucocidin toxoid against staphylococcal infection.

Authors:  J R Bänffer; J F Franken
Journal:  Pathol Microbiol (Basel)       Date:  1967
View more
  3 in total

1.  Leucotoxic activities of Staphylococcus aureus strains isolated from cows, ewes, and goats with mastitis: importance of LukM/LukF'-PV leukotoxin.

Authors:  Pascal Rainard; Juan-Carlos Corrales; M Belén Barrio; Thierry Cochard; Bernard Poutrel
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins.

Authors:  G Supersac; G Prevost; Y Piemont
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

3.  Enzyme-linked immunosorbent assay for detection of leukocidin toxin from Staphylococcus aureus in bovine milk samples.

Authors:  D A Loeffler; M T Creasy; N L Norcross; M J Paape
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.